B2B Healthcare Marketing · Nashville, TN

We architect the foundational marketing and sales systems that drive cost-effective growth.

Healthcare is the only market we work in. We start by unlocking the core GTM systems that align your revenue teams, strategy, positioning, measurement, and brand, and build a foundation your team owns.


Who we serve

Petrarch Strategy helps healthcare organizations build sustainable, long-term revenue growth — with evidence-based strategy grounded in real buyer behavior. We do that work across every corner of the industry.

01

Behavioural & Mental Health

02

04

Payers & Risk-Bearing Entities

07

Life Sciences & Pharma Services

10

Medical Devices & Health Hardware

Health IT & SaaS

05

Precision Medicine & Diagnostics

08

Value-Based & Population Health

11

Data, Analytics & AI

03

Healthcare Services

06

Digital Health & Virtual Care

09

Revenue Cycle & Health Finance

12

PE / VC-Backed Healthcare

Our Capabilities

The full range of marketing capability, applied to the only market we serve

The Petrarch Diagnostic — Commercial Assessment

A rigorous commercial assessment, category and growth analysis, brand and competitor research, and a buying-group study, that quantifies where your go-to-market is misaligned with how your market buys, and what to fix first.

Core Strategy, Positioning & Brand

Product, pricing, positioning and brand worked out as one system, the canonical answer to what you are, for whom, and why.

Thought Leadership & Editorial Authority

The standing authority engine, editorial programs and executive thought leadership that make you the company buyers remember first.

Buying-Group & Market Research

Map the committee behind the purchase: who decides, how each member weighs value and risk, and what stalls consensus.

GTM Systems & Measurement Integrity

The systems of record that unite marketing and sales, with a measurement model that reflects real growth instead of vanity metrics.

Sales Enablement & Revenue Alignment

The enablement that arms sales for a multi-stakeholder committee and keeps every revenue team aligned on the same evidence.

Why this matters

The B2B revenue playbook was never built to grow your business. It was engineered to sell you software.

Over two decades, an entire revenue function — go-to-market, sales, and marketing alike — was rebuilt around the tools that promised to measure it. The MQL, the intent signal, the attribution model, the dashboard: each was designed for what software could capture, not for how buyers decide. Instead of growth, it produces dependence — the appearance of certainty, sold back to the teams who must answer to a board.

In healthcare, the playbook breaks down entirely. There is no intent signal for a clinical committee. No attribution model shortens an eighteen-month sales cycle. No volume of touchpoints moves a credentialed buyer who decides by consensus and reputation. The purchase is a years-long, multi-stakeholder, deeply human decision — and the company remembered first in the room is the one that gets bought, earned long before any signal fires.

Our Approach

We start from how growth actually happens.

Your team needs a foundation for growth grounded in evidence, expertise, and trust. Your company needs a strategic partner who understands how the industry actually buys. Your customers need to remember you long before they enter the market.

We build that foundation around your team — establishing your company as the authority your category turns to, and compounding your growth from there.

The evidence

How your market buys.

The research on how complex B2B purchases get made is unambiguous — and most of it contradicts the playbook healthcare marketing has been sold.

95%

of B2B buyers are not in the market right now. Only 5% are ready to buy in a given quarter.

6–10

decision-makers shape a typical complex B2B purchase — each weighing risk from a different seat.

90%

of buyers choose a vendor that was on their shortlist before the research ever began.

17%

of the buying journey is spent with potential suppliers — and just 5% with any single vendor.

Start here

The Petrarch Diagnostic

An evidence-based diagnosis of where your go-to-market is misaligned with how your market buys — and what to do first.

The Petrarch Diagnostic

"An evidence-based diagnosis of where your go-to-market is misaligned with how your market buys."

  • Where you're losing deals before they start

  • How your buyers actually make decisions

  • What to fix first — and in what order

  • A foundation built to compound over time